Maxime Beydon
YOU?
Author Swipe
View article: Short versus long-course antibiotic therapy for pyogenic liver abscess: an emulated target trial
Short versus long-course antibiotic therapy for pyogenic liver abscess: an emulated target trial Open
In our study, an antibiotic course of ≤30 days did meet the noninferiority threshold of 10% at 90 days compared with longer durations for relapse-free survival. Noninferiority was also met in the subgroup of drained patients but not in und…
View article: French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases Open
These recommendations provide a practical, individualized framework for cancer risk assessment in CIRD patients. By integrating adapted screening, prevention, and shared decision-making, they aim to optimize patient safety while preserving…
View article: OP0060 Low-dose Aspirin for Cardiovascular Disease Primary Prevention at Giant Cell Arteritis Diagnosis: Emulation of a Target Trial in the French Healthcare Data System (SNDS)
OP0060 Low-dose Aspirin for Cardiovascular Disease Primary Prevention at Giant Cell Arteritis Diagnosis: Emulation of a Target Trial in the French Healthcare Data System (SNDS) Open
View article: OP0168 CLINICAL IMPACT OF INCOMPLETE B-CELL DEPLETION IN ANCA-ASSOCIATED VASCULITIS PATIENTS RECEIVING MAINTENANCE RITUXIMAB THERAPY: A RETROSPECTIVE STUDY
OP0168 CLINICAL IMPACT OF INCOMPLETE B-CELL DEPLETION IN ANCA-ASSOCIATED VASCULITIS PATIENTS RECEIVING MAINTENANCE RITUXIMAB THERAPY: A RETROSPECTIVE STUDY Open
View article: Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX Open
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a severe monogenic disorder caused by somatic mutations in ubiquitin-like modifier activating enzyme 1 (UBA1), characterized by inflammation, cytopenias, and freq…
View article: Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three Decades
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three Decades Open
Gaucher disease (GD) is a rare autosomal‐recessive lysosomal disorder caused by glucocerebrosidase deficiency. In this study, we described the epidemiology of GD in France over more than three decades. The French GD registry (FGDR) include…
View article: Some superiority trials with nonsignificant results published in high impact factor journals correspond to noninferiority situations: a research-on-research study
Some superiority trials with nonsignificant results published in high impact factor journals correspond to noninferiority situations: a research-on-research study Open
Noninferiority trials are designed to show that a new intervention is not worse in terms of efficacy than the reference intervention. It is adapted when the new intervention has an advantage in terms of safety, ease of use or cost over the…
View article: Conducting observational analyses with the target trial emulation approach: a methodological systematic review
Conducting observational analyses with the target trial emulation approach: a methodological systematic review Open
Objectives Target trial emulation is an approach that is increasingly used to improve transparency in observational studies and help mitigate biases. For studies declaring that they emulated a target trial, we aimed to evaluate the specifi…
View article: Création du club Greenternist : la médecine interne en transition écologique
Création du club Greenternist : la médecine interne en transition écologique Open
View article: Comorbidités et facteurs pronostiques de la maladie de Sjögren
Comorbidités et facteurs pronostiques de la maladie de Sjögren Open
La maladie de Sjögren est une affection auto-immune complexe, qui persiste à poser d'importants défis malgré les progrès de la recherche. Il s'agit d'une maladie rare dont la prévalence est estimée entre 0.01 % et 0.05 %. Son incidence est…
View article: Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study
Estimated prevalence, incidence and healthcare costs of Sjögren’s syndrome in France: a national claims-based study Open
Objectives To estimate prevalence, incidence and mortality rates, and annual healthcare costs of primary Sjögren’s syndrome (pSS) and SS associated with other autoimmune disorders (SS+AID) in France. Methods French national healthcare clai…
View article: The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation
The Sjögren's Working Group: The 2023 OMERACT meeting and provisional domain generation Open
View article: Effect of Lymphoma Treatment Approaches on Hematologic Response and Autoimmune Disease Activity in Sjögren's Patients with Lymphoma
Effect of Lymphoma Treatment Approaches on Hematologic Response and Autoimmune Disease Activity in Sjögren's Patients with Lymphoma Open
View article: Effect of Lymphoma Treatment Approaches on Hematologic Response and Autoimmune Disease Activity in Sjögren's Patients with Lymphoma
Effect of Lymphoma Treatment Approaches on Hematologic Response and Autoimmune Disease Activity in Sjögren's Patients with Lymphoma Open
View article: Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study
Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study Open
View article: OP0044 DOES RHEUMATOID ARTHRITIS PATIENTS' RISK OF OVERALL AND SITE SPECIFIC CANCER DIFFERS FROM THE GENERAL POPULATION? A NATIONAL CLAIMS DATABASE COHORT STUDY IN THE ERA OF BIOLOGICAL TREATMENTS
OP0044 DOES RHEUMATOID ARTHRITIS PATIENTS' RISK OF OVERALL AND SITE SPECIFIC CANCER DIFFERS FROM THE GENERAL POPULATION? A NATIONAL CLAIMS DATABASE COHORT STUDY IN THE ERA OF BIOLOGICAL TREATMENTS Open
View article: OP0233 IMPACT OF LYMPHOMA TREATMENT STRATEGY ON HEMATOLOGIC RESPONSE AND AUTOIMMUNE DISEASE ACTIVITY IN SJOGREN PATIENTS DEVELOPING LYMPHOMA
OP0233 IMPACT OF LYMPHOMA TREATMENT STRATEGY ON HEMATOLOGIC RESPONSE AND AUTOIMMUNE DISEASE ACTIVITY IN SJOGREN PATIENTS DEVELOPING LYMPHOMA Open
View article: Impact of patient ancestry on heterogeneity of Sjögren’s disease
Impact of patient ancestry on heterogeneity of Sjögren’s disease Open
Objectives We aimed to compare disease characteristics between primary Sjögren’s syndrome (pSS) patients of African ancestry (AA) and Caucasian ancestry. Methods We conducted a retrospective, case–control study in a French national and Eur…
View article: Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study
Autoantibodies against IFNα in patients with systemic lupus erythematosus and susceptibility for infection: a retrospective case-control study Open
View article: B‐cell lymphoma mimicking relapsing polychondritis
B‐cell lymphoma mimicking relapsing polychondritis Open
A 70-year-old man reported recent swelling and erythema of both ears, sparing the lobules and highly evocative of relapsing polychondritis (top left image). Moreover, a fluorodeoxyglucose positron emission tomography/computed tomography (P…
View article: <i>Bartonella and Coxiella</i> infections presenting as systemic vasculitis: case series and review of literature
<i>Bartonella and Coxiella</i> infections presenting as systemic vasculitis: case series and review of literature Open
Objectives Coxiella and Bartonella spp. display particular tropism for endothelial or endocardial tissues and an abnormal host response to infections with induced autoimmunity. We aimed, through a case series combined with a comprehensive …